A STUDY ON CORRELATION BETWEEN HBA1C AND SERUM LIPID PROFILE AMONG TYPE 2 DIABETES MELLITUS

Authors

  • Neha J Dutt Surat Municipal Institute of Medical Education and Research, Surat, Gujarat
  • Mit J Panchani Surat Municipal Institute of Medical Education and Research, Surat, Gujarat
  • Vandana K Dhangar Surat Municipal Institute of Medical Education and Research, Surat, Gujarat
  • Vinod A Dangde Surat Municipal Institute of Medical Education and Research, Surat, Gujarat

Keywords:

Type 2 diabetes mellitus, HB1AC, lipid profile

Abstract

Objective: To study correlation between HB1C and serum lipid profile among type 2 diabetes mellitus.

Methods: The cross-sectional study was carried out on 146 patients above the age of 30 years presenting with type 2 diabetes in OPD/wards of medicine department at Tertiary Care Center, South Gujarat.

Result: In study the parameters Fasting blood sugar (FBS), Glycated hemoglobin (HB1AC), triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), very low-density lipoprotein (VLDL)were studied. LDL, TC, were high in poor glycemic control group (HB1C>7) as compared to good glycemic control group (HB1C<7), HDL is significantly low in poor glycemic control group.

Conclusion: HB1AC is significantly correlated with lipid profiles. Type 2 diabetic patients are more prone to dyslipidaemia. Hba1c is significantly correlated with lipid profiles. So hba1c can be used as an indirect indicator of dyslipidaemia in type 2 diabetes in addition to as glycemic control biomarker.

Downloads

Published

2021-09-30

How to Cite

Dutt, N. J. ., Panchani, M. J. ., Dhangar, V. K. ., & Dangde, V. A. . (2021). A STUDY ON CORRELATION BETWEEN HBA1C AND SERUM LIPID PROFILE AMONG TYPE 2 DIABETES MELLITUS. National Journal of Medical Research, 11(03), 86–88. Retrieved from https://njmr.in/index.php/file/article/view/26

Issue

Vol. 11 No. 03 (2021)

Section

Original Research Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Author/s retain the copyright of their article,  with first publication rights granted to Medsci Publications.